Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
CELL THERAPEUTICS (NQ: CTIC)
1.330 USD  +0.080 (+6.40%)
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 18, 2013  /  Add to My Watchlist      
View: Quote News
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 1.250
Bid (Size) 1.320 (50000)
Ask (Size) 1.330 (22400)
Prev. Close 1.250
Today's Range 1.225 - 1.330
52wk Range 0.4208 - 3.939
Shares Outstanding 112,633,915
Dividend Yield N/A
Top News
More News
Preliminary Russell 3000 Addition Pushing Stocks Around
June 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8422632 for the full story. Read More
from StreetInsider.com News Articles
StreetInsider.com Pre-Open Movers 6/17: (KNDI) (NFLX) (AMD) Higher; (FOLD) (TEX) (ARMH) Lower (more...)
June 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8421957 for the full story. Read More
from StreetInsider.com News Articles

More News
Read More
CTI Announces New Data Presented at EHA 2013 Congress Demonstrating the Safety and Tolerability Profile of Pacritinib in Patients with Myelofibrosis
June 17, 2013
from PR Newswire
New EXTEND Analyses Evaluate Efficacy of Single Agent PIXUVRI® in 3rd and 4th Line Salvage Setting With and Without Prior Rituximab Treatment
June 17, 2013
from PR Newswire
Cell Therapeutics to Join Russell 3000® and Russell Global Indexes
June 17, 2013
from PR Newswire
StockCall Pre-Market Review on ACAD, DNDN, MDVN, CTIC, and SRPT
June 13, 2013
from ACCESSWIRE
CTI Announces Data Presentations at the 18th Congress of the European Hematology Association
June 11, 2013
from PR Newswire
Faruqi & Faruqi, LLP Launches An Investigation Against Cell Therapeutics, Inc. (CTIC) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors
June 05, 2013
from Business Wire News Releases
CTI Reports Final Results from Cooperative Group and NCI-Sponsored Trial of Brostallicin in Patients with Metastatic Triple-Negative Breast Cancer
June 01, 2013
from PR Newswire
Investors look to Lighten Up on Shares of Cell Therapeutics, Shares Down 5.2% (CTIC)
May 22, 2013
from Comtex SmarTrend® News Briefs
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here